Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1993 1
1999 1
2000 2
2001 3
2002 1
2003 10
2004 10
2005 12
2006 3
2007 24
2008 19
2009 20
2010 24
2011 26
2012 31
2013 24
2014 31
2015 26
2016 38
2017 40
2018 40
2019 40
2020 32
Text availability
Article attribute
Article type
Publication date

Search Results

408 results
Results by year
Filters applied: . Clear all
Page 1
Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetes.
Jung S, Bosch A, Kannenkeril D, Karg MV, Striepe K, Bramlage P, Ott C, Schmieder RE. Jung S, et al. Eur Heart J Cardiovasc Pharmacother. 2019 Dec 9:pvz078. doi: 10.1093/ehjcvp/pvz078. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2019. PMID: 31816038
There were greater decreases in 24-h ambulatory peripheral systolic (between-group difference: -5.2±1.5mmHg, p = 0.004), diastolic BP (-1.9±1.0mmHg, p = 0.036) and PP (-3.3±1.0mmHg, p = 0.007) in E+L than M+I. Central office systolic BP (-5.56±1.9mmHg, p
There were greater decreases in 24-h ambulatory peripheral systolic (between-group difference: -5.2±1.5mmHg, p = 0.004), diastolic BP …
PCSK9 inhibitors and cardiovascular outcomes.
Steffens D, Bramlage P, Scheeff C, Kasner M, Hassanein A, Friebel J, Rauch-Kröhnert U. Steffens D, et al. Expert Opin Biol Ther. 2020 Jan;20(1):35-47. doi: 10.1080/14712598.2020.1677604. Epub 2019 Oct 18. Expert Opin Biol Ther. 2020. PMID: 31593483
Impact of Dialysis on the Prognosis of Patients Undergoing Transcatheter Aortic Valve Implantation.
Schymik G, Bramlage P, Herzberger V, Bergmann J, Conzelmann LO, Würth A, Luik A, Schröfel H, Tzamalis P. Schymik G, et al. Am J Cardiol. 2019 Jan 15;123(2):315-322. doi: 10.1016/j.amjcard.2018.10.008. Epub 2018 Oct 18. Am J Cardiol. 2019. PMID: 30424871
At 30 days, there was an increased rate of all-cause mortality (21.4 vs 4.8%; adjOR 4.90, 95% CI 1.96 to 12.26; p = 0.001), cardiovascular (adjOR 3.67, 95% CI 1.43 to 9.41; p = 0.007) and noncardiovascular mortality (adjOR 6.28, 95% CI 1.36 to 9.41; p = 0.019 …
At 30 days, there was an increased rate of all-cause mortality (21.4 vs 4.8%; adjOR 4.90, 95% CI 1.96 to 12.26; p = 0.001), cardiovas …
Outcomes after transaortic transcatheter aortic valve implantation: long-term findings from the European ROUTE†.
Cocchieri R, Petzina R, Romano M, Jagielak D, Bonaros N, Aiello M, Lapeze J, Laine M, Chocron S, Muir D, Eichinger W, Thielmann M, Labrousse L, Rein KA, Verhoye JP, Gerosa G, Bapat V, Baumbach H, Sims H, Deutsch C, Bramlage P, Kurucova J, Thoenes M, Frank D. Cocchieri R, et al. Eur J Cardiothorac Surg. 2019 Apr 1;55(4):737-743. doi: 10.1093/ejcts/ezy333. Eur J Cardiothorac Surg. 2019. PMID: 30346515
New York Heart Association (NYHA) class III/IV (85.2% vs 71.8%, P = 0.017), Canadian Cardiovascular Society angina class III/IV (22.6% vs 11.4%; P = 0.021), pulmonary disease (32.6% vs 18.9%; P = 0.015) and renal insufficiency (15.7% vs 3.0%; P < 0. …
New York Heart Association (NYHA) class III/IV (85.2% vs 71.8%, P = 0.017), Canadian Cardiovascular Society angina class III/IV (22.6 …
Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial.
Barbanti M, van Mourik MS, Spence MS, Iacovelli F, Martinelli GL, Muir DF, Saia F, Bortone AS, Densem CG, van der Kley F, Bramlage P, Vis M, Tamburino C. Barbanti M, et al. EuroIntervention. 2019 Jun 20;15(2):147-154. doi: 10.4244/EIJ-D-18-01197. EuroIntervention. 2019. PMID: 30777842 Free article. Clinical Trial.
Patients appropriately discharged early had a significantly lower risk of the primary endpoint (7.0 vs. 26.4%; p<0.001) which was reflected in some of its relevant components: stroke (0.0 vs. 2.8%; p=0.015), PPI (4.3 vs. 15.9%; p<0.001), major vascular …
Patients appropriately discharged early had a significantly lower risk of the primary endpoint (7.0 vs. 26.4%; p<0.001) which was …
Outcomes of transfemoral balloon expandable transcatheter aortic valve implantation: Comparison of two subsequent valve generations.
Schymik G, Wendler O, Hengstenberg C, Ohlmann P, Gilard M, Digne F, Souteyrand G, Letocart V, van Belle E, Bramlage P, Tarantini G; SOURCE 3 and SOURCE XT Investigators. Schymik G, et al. Catheter Cardiovasc Interv. 2020 Oct 1;96(4):930-939. doi: 10.1002/ccd.28621. Epub 2019 Dec 3. Catheter Cardiovasc Interv. 2020. PMID: 31794159
A Cox regression predicting 1-year mortality resulted in a hazard ratio of 0.684 in favor of S3 (p = .0026). The same was true of stroke (2.8% vs. 5.7%; p = .0007), and moderate/severe PVL (2.7 vs. 7.3%; p = .0002) at 1 year. The rate of new pacemaker implant …
A Cox regression predicting 1-year mortality resulted in a hazard ratio of 0.684 in favor of S3 (p = .0026). The same was true of str …
Transcatheter aortic valve replacement- management of patients with significant coronary artery disease undergoing aortic valve interventions: surgical compared to catheter-based approaches in hybrid procedures.
Baumbach H, Schairer ER, Wachter K, Rustenbach C, Ahad S, Stan A, Hill S, Bramlage P, Franke UFW, Schäufele T. Baumbach H, et al. BMC Cardiovasc Disord. 2019 May 14;19(1):108. doi: 10.1186/s12872-019-1087-2. BMC Cardiovasc Disord. 2019. PMID: 31088373 Free PMC article.
Prior cardiac surgery was more common in TAVR+PCI than in TAVR+OP/MIDCAB and SAVR+CABG patients (p < 0.001). Procedural times were shortest (p < 0.001), creatine kinase (muscle brain) levels least elevated (p < 0.001), pericardial tamponade least com …
Prior cardiac surgery was more common in TAVR+PCI than in TAVR+OP/MIDCAB and SAVR+CABG patients (p < 0.001). Procedural times were …
Long-term outcome after mitral valve replacement using biological versus mechanical valves.
Cetinkaya A, Poggenpohl J, Bramlage K, Hein S, Doss M, Bramlage P, Schönburg M, Richter M. Cetinkaya A, et al. J Cardiothorac Surg. 2019 Jun 28;14(1):120. doi: 10.1186/s13019-019-0943-6. J Cardiothorac Surg. 2019. PMID: 31253187 Free PMC article.
Patients receiving biological valves were older (p < 0.001), had a higher log EuroSCORE (p < 0.001) and received less minimally invasive surgery (p < 0.001). ...The rate of re-thoracotomy (14.2%) was lower in the biological (12.5%) than in the mechan …
Patients receiving biological valves were older (p < 0.001), had a higher log EuroSCORE (p < 0.001) and received less mi …
Capnocytophaga canimorsus as Cause of Fatal Sepsis.
Hundertmark M, Williams T, Vogel A, Moritz M, Bramlage P, Pagonas N, Ritter O, Sasko B. Hundertmark M, et al. Case Rep Infect Dis. 2019 May 23;2019:3537507. doi: 10.1155/2019/3537507. eCollection 2019. Case Rep Infect Dis. 2019. PMID: 31240140 Free PMC article.
Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases.
Bramlage P, Lanzinger S, van Mark G, Hess E, Fahrner S, Heyer CHJ, Friebe M, Seufert J, Danne T, Holl RW. Bramlage P, et al. Cardiovasc Diabetol. 2019 Mar 16;18(1):33. doi: 10.1186/s12933-019-0837-x. Cardiovasc Diabetol. 2019. PMID: 30878037 Free PMC article.
They were older, had a longer diabetes duration and a higher proportion was females compared to patients without CKD (all p < 0.001). More than half of CKD patients (53.5%) were receiving long-acting insulin-based therapy versus around 39.1% of those without (p & …
They were older, had a longer diabetes duration and a higher proportion was females compared to patients without CKD (all p < 0.00 …
408 results
Jump to page
Feedback